Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Transcatheter Heart Valves Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Transcatheter Heart Valves Market, EU5
2.1 Transcatheter Heart Valves Market, EU5, Revenue ($m), 2024-2036
2.2 Transcatheter Heart Valves Market, EU5, Revenue ($m), 2024-2036
2.3 Transcatheter Heart Valves Market, EU5, Volume (Units), 2024-2036
2.4 Transcatheter Heart Valves Market, EU5, Volume (Units), 2024-2036
2.5 Transcatheter Heart Valves Market, EU5, Company Share by Revenue ($m), 2025
3 Transcatheter Heart Valves Market, France
3.1 Transcatheter Heart Valves Market, France, Revenue ($m), 2024-2036
3.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Transcatheter Heart Valves Market, France, Volume (Units), 2024-2036
3.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, France, Volume (Units), by Segment, 2024-2036
3.3 Transcatheter Heart Valves Market, France, Average Price ($), 2024-2036
3.4 Transcatheter Heart Valves Market, France, Company Share by Revenue ($m), 2025
4 Transcatheter Heart Valves Market, Germany
4.1 Transcatheter Heart Valves Market, Germany, Revenue ($m), 2024-2036
4.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Transcatheter Heart Valves Market, Germany, Volume (Units), 2024-2036
4.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Transcatheter Heart Valves Market, Germany, Average Price ($), 2024-2036
4.4 Transcatheter Heart Valves Market, Germany, Company Share by Revenue ($m), 2025
5 Transcatheter Heart Valves Market, Italy
5.1 Transcatheter Heart Valves Market, Italy, Revenue ($m), 2024-2036
5.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Transcatheter Heart Valves Market, Italy, Volume (Units), 2024-2036
5.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Transcatheter Heart Valves Market, Italy, Average Price ($), 2024-2036
5.4 Transcatheter Heart Valves Market, Italy, Company Share by Revenue ($m), 2025
6 Transcatheter Heart Valves Market, Spain
6.1 Transcatheter Heart Valves Market, Spain, Revenue ($m), 2024-2036
6.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Transcatheter Heart Valves Market, Spain, Volume (Units), 2024-2036
6.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Transcatheter Heart Valves Market, Spain, Average Price ($), 2024-2036
6.4 Transcatheter Heart Valves Market, Spain, Company Share by Revenue ($m), 2025
7 Transcatheter Heart Valves Market, United Kingdom
7.1 Transcatheter Heart Valves Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Transcatheter Heart Valves Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Transcatheter Heart Valves Market, United Kingdom, Average Price ($), 2024-2036
7.4 Transcatheter Heart Valves Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Transcatheter Heart Valves Market Pipeline Products
8.1 Transcatheter Heart Valves Market Pipeline Products
8.2 Transcatheter Heart Valves – Pipeline Products by Stage of Development
8.3 Transcatheter Heart Valves – Pipeline Products by Segment
8.4 Transcatheter Heart Valves – Pipeline Products by Territory
8.5 Transcatheter Heart Valves – Pipeline Products by Regulatory Path
8.6 Transcatheter Heart Valves – Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in EU5 Transcatheter Heart Valves Market
9.1 Edwards Lifesciences Corp
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Medtronic Plc
9.3.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Apr 07, 2026: Cambridge Appoints Pascal Levensohn as Chair of Its Innovation Hub Global Advisory Board
10.1.2 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.1.3 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.1.4 Oct 08, 2025: Job Opportunity at the Adaptive Brain Lab: Research Programme Manager Position
10.1.5 Oct 02, 2025: Utrecht University Researchers Identify Leading Sustainability Labels for Food
10.1.6 Oct 01, 2025: MRC Centre Of Research Excellence Round Four Now Open Internal Deadline 21st Oct 2025
10.1.7 Sep 24, 2025: Anna Von Der Heydt Appointed Professor Of Paleoclimate Dynamics
10.1.8 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
10.1.9 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
10.1.10 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
10.2 Financial Announcements
10.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
10.2.2 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
10.3 Government and Public Interest
10.3.1 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
10.3.2 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
10.3.3 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
10.4 Other Significant Developments
10.4.1 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
10.4.2 Oct 10, 2025: Medtronic Vietnam Deepens Collaboration With Hue Central Hospital Through Renewed Mou for Skill Building and Training
10.5 Product News
10.5.1 Nov 26, 2025: JenaValve Reports Positive Trilogy Heart Valve Data for Aortic Regurgitation
10.5.2 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
10.5.3 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
10.5.4 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.5.5 Nov 10, 2025: JenaValve's Trilogy System Featured in Live Procedure at TCT 2025
10.5.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
10.5.7 Sep 10, 2025: JenaValve Announces ESC Guidelines Recognize TAVI for Aortic Regurgitation
10.6 Strategy And Business Planning
10.6.1 Nov 20, 2025: New Propelus Prototype Centers
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 GlobalData Consulting
11.3 Contact Us
11.4 Disclaimer